The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas
Nicoletta Polerà(Magna Graecia University), Pierfrancesco Tassone(Temple University)
Cited by 3
Related Papers
Non-coding RNAs in cancer: platforms and strategies for investigating the genomic “dark matter”
|Journal of Experimental & Clinical Cancer Research|2020|270
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity
|Leukemia|2018|247
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1
|Cell Death and Disease|2012|161
Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro
|British Journal of Cancer|2003|155
Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma
|Molecular Cancer Therapeutics|2016|117